ロード中...
Structural modification of aspirin to design a new potential cyclooxygenase (COX-2) inhibitors
Aspirin (Asp) is one of the most important and ancient member of nonsteroidal anti-inflammatory drugs (NSAID), commonly used in medication of fever, pain and inflammation. It can inhibit the synthesis of prostaglandin by blocking the cyclooxygenase (COX). Attempts have been taken to analyze aspirin...
保存先:
| 出版年: | In Silico Pharmacol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7056757/ https://ncbi.nlm.nih.gov/pubmed/32181121 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40203-020-0053-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|